Xilio Therapeutics (XLO)
(Delayed Data from NSDQ)
$0.67 USD
+0.01 (1.40%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.67 0.00 (0.56%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Xilio Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
XLO 0.67 +0.01(1.40%)
Will XLO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XLO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XLO
Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates
After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright
XLO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for XLO
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XLO Stock News
Insider Moves: Top Executives Make Significant Stock Purchases at Xilio Therapeutics!
12 Health Care Stocks Moving In Wednesday's After-Market Session
Xilio Therapeutics Expands Authorized Shares at Annual Meeting